These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9052628)

  • 1. Cyclosporine monitoring with levels 6 hours after the morning dose in patients with noninfectious uveitis.
    Rocha G; Deschênes J; Cantarovich M
    Ophthalmology; 1997 Feb; 104(2):245-51. PubMed ID: 9052628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine dose adjustment using levels obtained six hours after the morning dose: effect on side effects in patients with autoimmune diseases.
    Cantarovich M; Deschênes J
    Am J Nephrol; 1997; 17(5):450-7. PubMed ID: 9382165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients.
    Cantarovich M; Besner JG; Fitchett DH; Latter DA
    Clin Transplant; 1997 Oct; 11(5 Pt 1):399-405. PubMed ID: 9361930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis.
    Deray G; Benhmida M; Le Hoang P; Maksud P; Aupetit B; Baumelou A; Jacobs C
    Ann Intern Med; 1992 Oct; 117(7):578-83. PubMed ID: 1524331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study.
    Isnard Bagnis C; Tezenas du Montcel S; Beaufils H; Jouanneau C; Jaudon MC; Maksud P; Mallet A; LeHoang P; Deray G
    J Am Soc Nephrol; 2002 Dec; 13(12):2962-8. PubMed ID: 12444215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cyclosporine monitoring in patients with chronic uveitis].
    Schmidt S; Pleyer U
    Ophthalmologe; 2005 Apr; 102(4):349-54. PubMed ID: 15726383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
    Zhang Y; Zhang XD; Wang Y
    Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cyclosporine monitoring with trough levels to levels obtained 6 hours after the morning dose in heart transplant patients: a prospective randomized study.
    Cantarovich M; Latter D; Fitchett D
    Transplant Proc; 1997; 29(1-2):602-4. PubMed ID: 9123149
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal outcome after ciclosporin-induced nephrotoxicity.
    Tostivint I; du Montcel ST; Jaudon MC; Mallet A; Le Hoang P; Bodaghi B; Deray G; Bagnis CI
    Nephrol Dial Transplant; 2007 Mar; 22(3):880-5. PubMed ID: 17127700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
    Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK
    J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
    White M; Pelletier GB; Tan A; Jesina C; Carrier M
    J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose cyclosporine treatment for sight-threatening uveitis: efficacy, toxicity, and tolerance.
    Mathews D; Mathews J; Jones NP
    Indian J Ophthalmol; 2010; 58(1):55-8. PubMed ID: 20029146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of C0 and C2 levels with cyclosporine side effects in kidney transplantation.
    Rodrigo E; Ruiz JC; Angeles de Cos M; Ruiz J; Gago M; Piñera C; Sánchez B; González-Cotorruelo J; Gómez-Alamillo C; Arias M
    Transplant Proc; 2009; 41(6):2328-31. PubMed ID: 19715910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis.
    Vitale AT; Rodriguez A; Foster CS
    Ophthalmology; 1996 Mar; 103(3):365-73; discussion 373-4. PubMed ID: 8600411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral.
    Sijpkens YW; Mallat MJ; Siegert CE; Zwinderman AH; Westendorp RG; de Fijter JW; van Es LA; Paul LC
    Clin Nephrol; 2001 Feb; 55(2):149-55. PubMed ID: 11269679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, Side Effects, and Monitoring of Oral Cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome.
    Crescenze IM; Tucky B; Li J; Moore C; Shoskes DA
    Urology; 2017 Sep; 107():49-54. PubMed ID: 28528859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.
    Neumayer HH; Budde K; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Clin Nephrol; 1996 May; 45(5):326-31. PubMed ID: 8738665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excellent results with high-dose mizoribine combined with cyclosporine, corticosteroid, and basiliximab in renal transplant recipients: multicenter study in Japan.
    Nishimura K; Uchida K; Yuzawa K; Fukuda Y; Ichikawa Y; Akioka K; Fujisawa M; Sugitani A; Ito S; Nakatani T; Horimi T; Yoshimura N
    Transplant Proc; 2012 Jan; 44(1):147-9. PubMed ID: 22310601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients.
    Mathias HC; Ozalp F; Will MB; Borland W; Payne C; Kerr M; Lockhart J; Murday AJ
    J Heart Lung Transplant; 2005 Dec; 24(12):2137-43. PubMed ID: 16364862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.